Organon & Co. Common Stock (NY:OGN)

13.72 +0.01 (+0.07%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Don't Overlook These Low-Risk High-Dividend Yielding Stocks ↗

February 24, 2024

Given the rally in the S&P 500 and the Nasdaq over the last year, it may be wise to consider stocks that should be less volatile during market corrections. Even better is when stocks have dividend...

Via Talk Markets

Topics Stocks

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks ↗

February 21, 2024

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Via Benzinga

Thursday Is Your Last Chance To Buy Organon Before The Dividend Payout ↗

February 20, 2024

Via Benzinga

Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary

February 20, 2024

From Organon & Co.

Via Business Wire

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Organon's Earnings: A Preview ↗

February 14, 2024

Via Benzinga

Looking Into Organon's Recent Short Interest ↗

January 22, 2024

Via Benzinga

Why Organon & Co. Stock Popped Today ↗

January 10, 2024

Organon & Co. (NYSE: OGN) shares traded higher on Wednesday after the company announced the availability of XACIATO 2% by prescription.

Via Benzinga

Why Is Women Health-Focused Organon Stock Trading Higher On Thursday? ↗

February 15, 2024

Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, driven by Follistim AQ's 63% growth. Biosimilar revenue surges by 49%.

Via Benzinga

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 15, 2024

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Via Benzinga

Analyst Expectations for Organon's Future ↗

November 22, 2023

Via Benzinga

Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday ↗

February 15, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Via Benzinga

Topics Stocks

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023

February 15, 2024

From Organon & Co.

Via Business Wire

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024

February 01, 2024

From Organon & Co.

Via Business Wire

Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts? ↗

January 30, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 29, 2024

Via Benzinga

Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts ↗

January 12, 2024

Via Benzinga

Topics Economy

Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older

January 10, 2024

From Organon & Co.

Via Business Wire

Merck, the Dow's hottest stock, gets set to report Q4 financials

January 08, 2024

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

Via MarketBeat

Topics Stocks

Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook

January 08, 2024

From Organon & Co.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts ↗

December 27, 2023

Via Benzinga

Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 21, 2023

From Organon & Co.

Via Business Wire

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

December 18, 2023

From Organon & Co.

Via Business Wire

Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts ↗

December 12, 2023

Via Benzinga

Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits ↗

December 05, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

November 27, 2023

Via Benzinga

Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True? ↗

November 21, 2023

High-yielding stocks may be tantalizing, but they often come with risks.

Via The Motley Fool

Organon To Present at the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

From Organon & Co.

Via Business Wire

Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts ↗

November 09, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.